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Introduction
The constitutive trafficking and secretion of newly synthesized 
proteins in mammalian cells is a complex, multistep pathway 
that is regulated by many protein and lipid families (Mellman 
and Warren, 2000). Key steps in this pathway include the forma-
tion of pleiomorphic, membrane-bound carriers for the transport 
of newly synthesized cargo through the cell (Bard and Malhotra, 
2006). The ability to track fluorescently tagged cargo by live-cell 
imaging has revealed much about the behavior of these carriers, 
but many aspects of protein transport in secretory pathways re-
main ill defined (Hirschberg et al., 1998; Polishchuk et al., 2000; 
Keller et al., 2001; De Matteis and Luini, 2008).
The abundant, constitutive secretion of proinflammatory 
cytokines in macrophages represents a biologically and clini-
cally important secretory pathway. Some features of this pathway   
are paradigmatic for eukaryotic cell function, whereas others 
have emerged as elegant adaptations for macrophage-specific 
functions in innate immunity (Murray et al., 2005a; Stow et al., 
2006). Activation of macrophages by lipopolysaccharide (LPS) 
or other toll-like receptor (TLR) ligands initiates the synthesis, 
trafficking, and secretion of proinflammatory cytokines (Gordon, 
2007; Stow et al., 2009). TNF is one of the major early response 
inflammatory cytokines released by macrophages. Although 
TNF is an essential proponent of inflammation and immunity, its 
overabundant secretion from activated macrophages in chronic 
inflammatory diseases is highly detrimental in a clinical context   
(Beutler, 1999). Therefore, it is imperative to fully define and under-
stand the regulators of TNF trafficking and secretion.
Newly synthesized transmembrane precursors of TNF are 
transported from the TGN to recycling endosomes from where 
TNF can be rapidly deployed to phagocytic cups or filopodia   
at the cell surface for cleavage and release (Murray et al., 2005a; 
Stow et al., 2009). LPS up-regulates the expression of spe-
cific membrane fusion proteins (Pagan et al., 2003; Murray   
et al., 2005b; Stow et al., 2006) and increases the budding of 
P
hosphoinositide  3-kinase  (PI3K)  p110  isoforms 
are membrane lipid kinases classically involved 
in  signal  transduction.  Lipopolysaccharide  (LPS)- 
activated macrophages constitutively and abundantly se-
crete proinflammatory cytokines including tumor necrosis 
factor- (TNF). Loss of function of the p110 isoform of 
PI3K using inhibitors, RNA-mediated knockdown, or ge-
netic inactivation in mice abolishes TNF trafficking and 
secretion, trapping TNF in tubular carriers at the trans-
Golgi network (TGN). Kinase-active p110 localizes to 
the  Golgi  complex  in  LPS-activated  macrophages,  and 
TNF is loaded into p230-labeled tubules, which cannot 
undergo fission when p110 is inactivated. Similar blocks 
in fission of these tubules and in TNF secretion result from 
inhibition  of  the  guanosine  triphosphatase  dynamin  2. 
These findings demonstrate a new function for p110 as 
part of the membrane fission machinery required at the 
TGN for the selective trafficking and secretion of cytokines 
in macrophages.
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which is consistent with its relatively short half-life (Fig. S1 B; 
Vanhaesebroeck and Waterfield, 1999). At these concentra-
tions, both drugs are known to inhibit most subtypes of PI3K, 
particularly the class I kinases (Fruman et al., 1998). Secondary 
testing using specific inhibitors to the different class I catalytic 
isoforms was performed (Fig. 1 B). LPS-stimulated TNF secre-
tion was significantly reduced (by 60%) by 5 µM IC87114, at 
which concentration this inhibitor is highly selective for p110 
(Sadhu et al., 2003). The p110-selective inhibitor TGX221 
also affected TNF secretion at the highest concentration tested   
(500 nM), which can also inactivate p110 (Jackson et al., 2005). 
In contrast, other p110 inhibitors had only marginal effects on 
TNF secretion. These results provided initial evidence that PI3K, 
specifically its p110 isoform, is active in modulating the consti-
tutive secretion of TNF.
The trafficking of TNF to the cell surface in LPS-activated 
macrophages can be assayed by sequential immunostaining   
of plasma membrane and intracellular pools of TNF (Pagan   
et al., 2003). LPS-activated macrophages incubated with a TNF-
converting enzyme (TACE) inhibitor to block proteolytic release 
of TNF can be fixed and stained without permeabilization to 
detect surface-retained TNF (Fig. 1 C); subsequent permeabili-
zation then allows for labeling of intracellular TNF, typically at 
the perinuclear Golgi complex (Fig. 1 C; Shurety et al., 2000). 
LY294002 treatment resulted in dramatically reduced surface 
staining of TNF, but TNF was still present inside the cells, de-
tected as strong perinuclear Golgi staining (Fig. 1 C). To quan-
titate the effects of p110 inhibition on the cell surface delivery 
of TNF, macrophages treated for 2 h with 5 µM IC87114 or 
pan-PI3K inhibitors (15 nM wortmannin or 25 µM LY294002) 
were subjected to similar staining procedures for flow cytomet-
ric analysis. All inhibitors caused a >60% reduction in staining 
intensity of surface TNF, relative to control cells, whereas stain-
ing of intracellular TNF was not significantly affected (Fig. 1 D 
and Fig. S2 A). Collectively, these data show that pan-PI3K or 
p110-selective pharmacologic inhibition blocks the surface de-
livery and secretion of TNF, without affecting its de novo synthe-
sis. Moreover, inactivation of p110 alone was as efficacious in 
blocking TNF surface delivery as pan-PI3K inhibition, suggest-
ing that p110 is the sole or predominant PI3K isoform active in 
this trafficking pathway.
TNF trafficking is blocked by siRNA-
mediated knockdown of p110 and by its 
genetic inactivation in mice
To directly test the requirement for p110 in transporting TNF 
to the cell surface, small interfering (si) RNA knockdown was 
used to silence p110 expression in RAW264.7 macrophages. 
Three siRNAs were designed to target p110, and one (siRNA3) 
effectively reduced the levels of endogenous p110 in total cell 
lysates by 90% (Fig. 2 A) and diminished immunostaining of 
p110 in cells (Fig. 2 B). Immunostaining revealed a somewhat 
unexpected perinuclear concentration of p110 staining in the 
Golgi region that correspondingly disappeared with the knock-
down. In response to LPS, the amount of TNF secreted was 
shown to correlate inversely with the level of p110 knockdown 
(Fig. 2 C). In siRNA3-treated cells, staining of TNF at the cell 
TGN-derived membrane carriers to facilitate TNF trafficking 
and secretion (Lock et al., 2005; Lieu et al., 2008). Thus, in 
macrophages, key features of constitutive secretion are tightly 
linked to cell activation, presumably through cell signaling path-
ways. How signaling and membrane trafficking are coordinated 
during macrophage activation is unclear, and thus, we sought to 
identify additional regulators involved in stimulus-coupled cyto-
kine release.
Phosphoinositide 3-kinases (PI3Ks) are ubiquitous modu-
lators of cellular membrane lipids for signaling and trafficking 
events. Members of the three mammalian PI3K classes (I–III), 
which differ in their molecular structures and substrate speci-
ficities,  generate  3-phosphorylated  phosphoinositides  on  the 
cytoplasmic leaflet of membrane bilayers for diverse roles in 
signal transduction, cytoskeletal dynamics, and membrane traf-
ficking (for reviews see Martin, 1998; Vanhaesebroeck et al., 
2001; Di Paolo and De Camilli, 2006). The classical signal-
transducing  class  I  PI3Ks  are  heterodimers  comprising  four 
catalytic isoforms (p110, p110, p110, or p110) complexed 
to their membrane-targeting adaptors. These represent the only 
class of PI3Ks that can metabolize phosphatidylinositol-4,5-
bisphosphate (PtdIns(4,5)P2) to yield phosphatidylinositol-
3,4,5-bisphosphate (PtdIns(3,4,5)P3) in vivo, often in response 
to cell activation. PtdIns(3,4,5)P3 plays a major role in delineat-
ing docking sites for a variety of protein effectors possessing 
the pleckstrin homology domains, including serine/threonine 
kinases, tyrosine kinases, nucleotide exchange factors, and   
GTPases, which control a diversity of cellular functions, exqui-
sitely under PI3K regulation (Vanhaesebroeck and Waterfield, 
1999; Deane and Fruman, 2004). Class I PI3Ks have not pre-
viously been implicated in regulation of constitutive secretion 
(Lindmo and Stenmark, 2006).
In this study, our experiments led us to examine a role for 
PI3K in TNF secretion in macrophages. Our findings show a new 
and unexpected function for one member of the class I PI3K sub-
family in intracellular trafficking at the level of the TGN.
Results
The p110 isoform of PI3K regulates 
constitutive secretion of TNF
As one approach to identifying molecular regulators of intra-
cellular TNF trafficking, a screen of pharmacologic agents was per-
formed in LPS-activated mouse macrophages. Results showed   
that treatment with either of the pan-PI3K inhibitors, wortmannin 
or LY294002, altered TNF secretion. In an earlier study, wortman-
nin added before LPS was found to increase the amount of 
TNF secreted from peritoneal macrophages (Park et al., 1997). 
Inhibitors in our experiments were added with LPS to modify 
subsequent trafficking, and under these conditions, wortman-
nin and LY294002 strikingly suppressed TNF secretion over 
a 6-h time course in RAW264.7 cells (Fig. 1 A). Titrated into 
culture  supernatants,  LY294002  reduced  TNF  secretion  in 
a  concentration-dependent  manner,  optimally  at  >25  µM  (by 
6080%) over the time course (Fig. S1 A). The more po-
tent wortmannin maximally reduced TNF secretion by up to 
70% at low nanomolar concentrations (<250 nM) over 6 h,   1055 PI3K regulates Golgi carrier fission for secretion • Low et al.
kinase-dead plasmid (p110-kd; Fig. S3 B) nor by overexpres-
sion of a different PI3K (PI3KC2; Fig. S3 C). These data thus 
provide evidence that the expression and kinase activity of p110 
is essential and nonredundant for effective cell surface delivery 
and secretion of TNF.
The in vivo function of p110 can be studied in p110 
knockout mice (Clayton et al., 2002; Jou et al., 2002) and in 
mice  lacking  active  p110,  owing  to  a  germline-inactivating 
knockin mutation (D910A) engineered in the p110 kinase do-
main (Okkenhaug et al., 2002). Unlike the other class I PI3Ks, 
p110 is predominantly and most highly expressed in leukocytes 
surface was abolished (Fig. 2 B), and the level of secreted TNF 
in these cultures was decreased by >60% compared to controls 
or to cells transfected with siRNAs targeting other p110 isoforms   
(Fig. 2 C and not depicted). A rescue experiment was performed 
to rule out the possibility of siRNA off-target effects (Fig. 2 D and   
Fig. S3). Cells depleted of p110 with siRNA3 were retransfected 
with an siRNA-resistant, wild-type (WT) plasmid (p110-WT).   
In cells now stained for exogenous p110, TNF staining was   
restored at the cell surface (Fig. 2 D and Fig. S3 A), indicating full   
rescue of TNF surface delivery. However, this rescue was not 
observed in cells transfected instead with an siRNA-resistant, 
Figure 1.  PI3K inhibition and TNF secretion. (A) RAW264.7 macrophages were stimulated with LPS in the presence of vehicle DMSO or either 15 nM 
wortmannin or 50 µM LY294002, and supernatants were sampled at the times indicated to measure TNF secretion by ELISA. (B) TNF secretion 2 h after LPS 
activation and treatment with p110-selective inhibitors (YM024 [p110], TGX221 [p110], IC87114 [p110], or AS252524 [p110]) at the concentra-
tions indicated. The following indicate statistical significance at the lowest effective concentrations: ** (IC87114), P = 0.0025; ** (TGX221), P = 0.0073; 
* (YM024), P = 0.116. (C) Epifluorescence of RAW264.7 cells stimulated with LPS for 1 h in the presence of a TACE inhibitor, TAPI, to retain surface TNF. 
Cells treated with DMSO alone or with 50 µM LY294002. Immunostaining of surface TNF (red) on unpermeabilized (unperm) cells was followed by stain-
ing of intracellular TNF (green) after permeabilization (perm). DAPI (blue) labeling depicts nuclei. Bars, 10 µm. (D) Flow cytometric analysis of intracellular 
TNF (Alexa Fluor 488) and surface TNF (PE) staining in activated cells treated with DMSO, 15 nM wortmannin, 25 µM LY294002, or 5 µM IC87114 
for 2 h. Mean fluorescence intensity of TNF staining in Alexa Fluor 488 or PE channel expressed as mean ratio ± SEM relative to DMSO. Corresponding 
representative overlay histograms are displayed. (A–D) All results are representative of three independent experiments. Error bars indicate mean ± SD.JCB • VOLUME 190 • NUMBER 6 • 2010   1056
in  RAW264.7  cells  (Manderson  et  al.,  2007).  Upon  LPS   
activation, both WT and p110
D910A/D910A BMMs produce IL-6,   
which  was  secreted  alongside  TNF  (Fig.  3  B).  Activated 
p110
D910A/D910A BMMs secreted IL-6 at levels similar to WT 
cells, which is consistent with only a modest impact of p110 
inactivation on secretion of this cytokine. Therefore, loss of 
p110  activity  selectively  inhibits  the  trafficking  and  secre-
tion of TNF but not IL-6 in BMMs. Although IL-6 secretion 
is  not  regulated  by  p110,  it  could  nevertheless  be  reduced 
in  RAW264.7  cells  treated  with  LY294002  or  wortmannin   
(Fig. S1, C and D, respectively), suggesting that other PI3K iso-
forms might be involved.
To confirm whether the observed reduction in TNF se-
cretion from p110
D910A/D910A BMMs reflects a block in intra-
cellular trafficking, cells were activated in the presence of the 
TACE inhibitor and stained for TNF for flow cytometric analy-
sis. p110
D910A/D910A BMMs exhibited >80% lower surface TNF 
staining intensity than WT cells (Fig. 3 C and Fig. S2 B) despite 
similar  levels  of  intracellular TNF. When  individual  BMMs 
were visualized by confocal microscopy, surface TNF stain-
ing on p110
D910A/D910A cells was minimal or absent, whereas 
intracellular  TNF  staining  was  still  conspicuous  (Fig.  3  D) 
and colocalized with GM130 at the Golgi complex (Fig. 3 E).   
Thus, these findings clearly show that p110
D910A/D910A BMMs 
still produce TNF but are defective in secreting it. This confirms 
(Vanhaesebroeck et al., 1997; Okkenhaug and Vanhaesebroeck, 
2003). Accordingly, homozygous mice with knockout or kinase-
inactive mutant p110 are viable but have a variety of immune 
cell  signaling  and  functional  defects  (Vanhaesebroeck  et  al., 
2005). The knockin transgenic strategy used to generate the 
p110
D910A/D910A mice provides an opportunity to investigate loss 
of p110 kinase function without interfering with the molecular 
balance of other p110 isoforms and their associated adaptor sub-
units (Okkenhaug et al., 2002; Ali et al., 2004).
Therefore,  we  isolated  bone  marrow–derived  macro-
phages (BMMs) from p110
D910A/D910A mice and WT littermates 
to study cytokine trafficking and secretion. Unstimulated WT 
and p110
D910A/D910A BMMs showed negligible TNF produc-
tion or secretion (Fig. 3, A and C), as expected. In response to 
LPS stimulation, TNF secretion was detected in supernatants of 
both WT and p110
D910A/D910A BMMs by 2 h, and its secretion 
was maintained at high levels from 4–10 h only in WT cultures 
(Fig.  3 A).  In  contrast, TNF  secretion  from  p110
D910A/D910A  
BMMs  was  severely  reduced  by  70–80%  throughout  the  time 
course.  This  closely  recapitulated  the  effects  of  IC87114  on 
LPS-stimulated secretion of TNF from RAW264.7 macrophages 
(Fig. 1 B). We also tested the ability of p110
D910A/D910A BMMs 
to  effectively  secrete  cytokines  other  than  TNF.  Interleukin-6 
(IL-6) is another proinflammatory cytokine whose biosyn-
thetic trafficking pathway partially overlaps with that of TNF   
Figure 2.  siRNA knockdown of p110 impairs TNF secretion. (A) Levels of p110 protein (115 kD; loading control actin, 40 kD) in cell lysates mea-
sured by Western blotting 48 h after transfection with specific siRNAs or controls. (B) Immunostaining of p110 (red) and TNF (green) in cells after LPS acti-
vation in the presence of TAPI. siRNA3-transfected cells show reduced staining for both proteins. (C) Supernatants from mock-transfected (control) cells and 
cells transfected with p110-targeting siRNAs were used to measure TNF secretion by ELISA. Normalized to total protein, data are expressed as mean ± 
SEM from triplicate transfections. *, P = 0.0218. (D) Rescue of p110 siRNA knockdown. Expression of siRNA-resistant WT p110 (immunostained in red) 
in p110-si–transfected cells. Rescued cells show surface staining for TNF (green). LPS-activated cells were treated with TAPI, fixed, and immunostained. 
Phalloidin (white) was used to outline cells. Bars, 10 µm.1057 PI3K regulates Golgi carrier fission for secretion • Low et al.
Immunostaining of p110 in LPS-activated RAW264.7 macro-
phages produced diffuse cytoplasmic staining and also concen-
trated p110 labeling over the perinuclear Golgi complex that 
was costained for GM130 (Fig. 4 A). Staining with available 
antibodies to other isoforms produced only diffuse cytoplasmic 
staining, as shown for p110 (Fig. 4 A). This reveals a novel local-
ization for p110.
A biochemical approach was then used to assess and 
characterize the association of p110 with Golgi membranes. 
Stacked  Golgi  membranes  fractionated  from  homogenates   
in primary cells that inactivation of p110 does not affect the 
synthesis of TNF, nor its accumulation in the Golgi complex, 
but that subsequent delivery to the cell surface for secretion   
is impaired.
LPS-inducible Golgi localization of p110
We next examined the localization and possible site of action   
for p110 in macrophages. The p110 subunits of PI3K in various 
cell types are typically present in the cytoplasm or associated   
with plasma- and endomembranes at sites of their activation.   
Figure 3.  Impaired trafficking and secretion of TNF in macrophages from genetically inactivated p110 mice. (A and B) Supernatants from LPS-stimulated 
WT and p110
D910A/D910A BMM cultures were collected every 2 h over a 10-h time course for ELISA measurements of secreted TNF (A) and IL-6 (B). Results 
indicate mean ± SEM from three littermates of each genotype. ND, not detected. (C) Flow cytometric analysis of intracellular and surface TNF staining 
in WT and p110
D910A/D910A BMMs treated with LPS and TAPI for 2 h. Mean fluorescence intensity in each TNF channel expressed as mean ratio ± SEM 
relative to LPS-stimulated WT from three independent experiments. ***, P < 0.001. Representative overlay histograms are shown for LPS-stimulated WT 
and p110
D910A/D910A BMMs. (D and E) Confocal analysis of TNF staining in activated WT and p110
D910A/D910A BMMs in the presence (D) or absence 
(E) of TAPI for 2 h. (D) Surface (red) and intracellular (green) TNF staining. Magnified images in D show BMMs costained with phalloidin (blue) to depict 
surface actin. (E) Intracellular TNF (green) in BMMs costained with the Golgi marker GM130 (red). Differential interference contrast images are included 
to define cells. Bars, 10 µm.JCB • VOLUME 190 • NUMBER 6 • 2010   1058
in  vitro  with  GTP-S  (Murray  et  al.,  2005b;  Manderson   
et al., 2007). In this study, a similar preparation was per-
formed,  and  blotting  revealed  that  p110  was  recovered 
mainly in the cytosol. p110 was not detected as a resident 
protein on newly isolated or remnant Golgi membranes after 
budding;  however,  p110  was  recruited  to  membranes  of 
budded carriers (Fig. 4 B). This carrier fraction also contained 
TNF as cargo. The adaptor protein -adaptin, which is also 
recruited from cytosol to carrier membranes, was blotted as a 
control to demonstrate carrier budding. These results confirm 
the transient association of p110 with Golgi-derived mem-
branes and further posit carrier membranes as a possible site 
of action for p110.
To further demonstrate an in situ recruitment of p110 to 
Golgi membranes in response to acute LPS activation, we per-
formed immunostaining of p110 on perforated RAW264.7 
macrophages from which the cytosol was depleted, leaving 
behind attached organelles (Wylie et al., 1999). The retention 
of nuclei and perinuclear Golgi complexes in cell remnants is 
shown by DAPI and GM130 labeling, respectively (Fig. 4 C). 
In unstimulated cells, some immunostained p110 remained 
associated with Golgi after cell disruption. LPS activation of 
cells before disruption revealed markedly stronger staining of 
p110 on the Golgi as early as 30 min and at 2 h as shown 
(Fig. 4 C, Fig. S4, and Video 1), which is consistent with re-
cruitment of the kinase to these membranes. Strikingly, the 
timing of this LPS-inducible recruitment of p110 correlates 
with the trafficking of a Golgi pool of newly synthesized TNF 
(Shurety et al., 2000) and with up-regulation of other known 
machinery needed for this trafficking (Murray et al., 2005a).
TNF accumulates in Golgi-derived tubular 
carriers after PI3K inactivation
Newly synthesized TNF transported out of the Golgi com-
plex moves to recycling endosomes before its final delivery 
to the cell surface (Murray et al., 2005a; Braun et al., 2007; 
Manderson et al., 2007). Our results to this point suggested 
that p110 may be acting at the Golgi before the delivery   
of TNF to recycling endosomes. To further substantiate the   
requirement of PI3K activity in Golgi export of TNF to re-
cycling endosomes, cells that had accumulated intracellular 
TNF during PI3K inhibition were colabeled with either trans-
ferrin receptor (TfnR) as a recycling endosomal marker or 
with GM130. In control cells, TNF and TfnR staining over-
lapped  in  some  peripheral  recycling  endosomes  (Fig.  5 A). 
However, after PI3K inhibition, little or no TNF was ob-
served in these TfnR-labeled structures, whereas TNF was 
still broadly colocalized with GM130 at the Golgi complex. 
This confirms that PI3K inhibition blocks transport of TNF 
before it is delivered to recycling endosomes, precisely at its 
point of exit from the TGN. Upon close examination of fixed 
macrophages treated with LY294002 (Fig. 5, A and B) or 
IC87114 (not depicted), we noted the de novo appearance of 
multiple TNF-stained tubules emanating from Golgi com-
plexes. These tubules were reminiscent of tubular extensions 
of  the  TGN  seen  in  live  cells  (Polishchuk  et  al.,  2000;   
De Matteis and Luini, 2008), and they specifically resembled 
Figure 4.  Localization of p110 on Golgi membranes. (A) Confocal imag-
ing reveals the diffuse cytoplasmic and Golgi immunostaining of p110 
(red) colocalized with GM130 (green; magnified) in RAW264.7 macro-
phages activated by LPS for 2 h. p110 (red) gave mostly cytoplasmic 
immunostaining. (B) Stacked Golgi membranes prepared from activated 
RAW264.7 macrophages were incubated in vitro with cytosol and GTP-S 
to generate budded carriers. The remnant Golgi membranes, budded car-
riers, and cytosol were collected by ultracentrifugations. Samples of these 
fractions were run on gels (25% of cytosol supernatants; whole membrane 
pellets) and immunoblotted for p110 and -adaptin as a peripheral pro-
tein marker of TGN-derived budded carriers and TNF as cargo. (C) Cover-
slip-adherent RAW264.7 macrophages were stimulated with LPS over an 
acute time course. Immunostaining for p110 (red) and GM130 (green) 
was performed at times 0, 30 min, and 2 h on ripped-open cells that ex-
posed intact Golgi membranes. At least 20 cells were analyzed per three 
independent experiments. Arrows highlight colocalization of p110 with 
GM130. DAPI (blue) labeling depicts nuclei. Bars, 10 µm.
of LPS-activated RAW264.7 cells contain TNF precursors as 
cargo; moreover, this TNF cargo can be recovered in a subset   
of carriers budded from the Golgi membranes after incubation   1059 PI3K regulates Golgi carrier fission for secretion • Low et al.
in activated RAW264.7 macrophages treated with LY294002 
revealed tubules bearing both p230 and TNF labels (Fig. 5 E), 
indicating that the tubules seen under PI3K inhibition are bona 
fide TGN-derived tubular carriers for TNF.
Inactivation of p110 blocks fission of TGN 
tubular carriers in live macrophages
Our findings increasingly pointed to a novel role for p110 at 
the level of TGN-derived exocytic tubular carriers. TGN car-
rier formation was then examined by high resolution, real-time   
imaging in live, activated RAW264.7 macrophages coexpressing 
YFP-p230GRIP and TNF-mCherry. YFP-p230GRIP tubules loaded 
with boluses of TNF-mCherry cargo were recorded emerging 
from the Golgi complex, often extending (up to 7 µm) and 
rapidly (within 5.5 s) undergoing fission to release one or more 
boluses of TNF-mCherry (Fig. 6 A and Video 2).
When macrophages were activated in the presence of 
wortmannin (Fig. 6 B and Video 3) or IC87114 (Fig. 6 C and 
Video  4), YFP-p230GRIP  tubules  loaded  with  TNF-mCherry 
cargo were also observed, confirming patent cargo loading and 
formation of tubular carriers. However, inhibitor treatment   
the  TNF-carrying  tubular  carriers  we  have  previously  re-
ported (Lock et al., 2005; Lieu et al., 2008). Immunostaining 
confirmed the presence of TNF in these tubules and appro-
priately, the Golgi-resident protein GM130 was detected in 
the source Golgi complex but not in the tubules themselves 
(Fig. 5, B and C). Such tubular carriers are typically highly 
dynamic and therefore seen most readily in live cells (Lock 
et al., 2005). Their appearance in fixed macrophages after 
PI3K  inhibition  suggested  enhanced  activity  or  stability. 
Counting confirmed a marked >85% increase in TNF-stained, 
Golgi-associated  tubules  after  incubation  with  pan-PI3K   
inhibitors (Fig. 5 D).
Proteins in the GRIP-golgin subfamily bind to and de-
lineate  distinct  subdomains  of  the  TGN  and  tubular  carri-
ers arising therefrom (Munro and Nichols, 1999; Gleeson   
et al., 2004). The tubules responsible for transporting TNF as 
cargo are specifically demarked by the GRIP-golgin p230 (also 
known as golgin-245 or t–golgin-1) and can be labeled by 
expression of the YFP-tagged, membrane-binding GRIP do-
main of p230 (YFP-p230GRIP; Gleeson et al., 2004; Lock et al., 
2005). Cotransfection of this YFP-p230GRIP and TNF-mCherry 
Figure 5.  Site of action for PI3K in TNF secretory pathway. (A–C) LPS-activated RAW264.7 macrophages were incubated with DMSO or 50 µM LY294002 
for 2 h, fixed, and immunostained for TNF (red) and, in green, either TfnR (A) or GM130 (B and C). Arrows in A point to multiple TNF-labeled tubules 
extending from the Golgi complex, and the arrow in B indicates one of these tubules labeled for TNF but not GM130. (C) 3D tomographic reconstructions 
of confocal z sections (0.48 µm) show multiple discrete TNF-positive tubules (arrows) after treatment with LY294002. DAPI (blue) labeling depicts nuclei. 
(D) TNF tubules were counted in cells from five fields (40–50 cells/field). Error bars indicate mean ± SEM. **, P = 0.0077. (E) RAW264.7 macrophages   
were transiently transfected with YFP-p230GRIP (green) and TNF-mCherry (red) for 2 h and treated with 50 µM LY294002 for 1 h before fixation for con-
focal microscopy. Arrows indicate two tubules (3 and 13 µm in length). (A–C and E) Regions of colocalization or interest are indicated by boxes and are 
magnified in insets. Bars: (A, B, and E) 20 µm; (C) 10 µm.JCB • VOLUME 190 • NUMBER 6 • 2010   1060
LPS-recruited active p110 at the Golgi, congruent with the 
need to export newly synthesized TNF.
To further define how tubular fission is disrupted by in-
activation of p110, we turned to other proteins known to induce 
membrane fission of Golgi-derived carriers. Such molecules in-
clude dynamin 2 (Dyn2), a large GTPase implicated in fission of 
TGN tubules transporting biosynthetic cargo (Jones et al., 1998; 
Cao et al., 2000; Kreitzer et al., 2000). Dyn2 also reportedly co-
localizes with p230 at the TGN (Yang et al., 2001). When Dyn2 
was overexpressed in activated macrophages, it broadly colocal-
ized with YFP-p230GRIP on the TGN in addition to giving finely 
punctate, cytoplasmic immunostaining (Fig. 7 C). Treatment with 
IC87114 to inactivate p110 dramatically diminished Dyn2 stain-
ing at the TGN in most cells (Fig. 7 C). Image analysis of TGN to 
cytoplasmic pixel intensities confirmed this loss of Dyn2 at the 
TGN (Fig. 7 D). This result confirms the dynamic recruitment 
of Dyn2 to TGN membranes seen previously in other cells (Cao 
et al., 2000; Kreitzer et al., 2000) and newly implicates PI3K 
in Dyn2 recruitment. We also tested the functional consequence 
of blocking Dyn2 in preliminary experiments using the dynamin 
GTPase inhibitor dynasore (Macia et al., 2006). Dynasore treat-
ment effectively abrogated LPS-stimulated TNF secretion com-
parable to the reduction observed from p110
D910A/D910A BMMs, 
resulted in tubules that remained remarkably inactive after   
forming and did not release TNF-mCherry, even over prolonged 
periods of recorded time (≥30 min). These tubules were able to ex-
tend (to 5–8 µm) and retract normally during observation periods,   
showing that their movement by itself was unaffected, but they 
remained atypically attached to the TGN, denoting fission as the 
likely defective step. Quantification confirmed that the frequency 
of fission events in live cells was over twofold lower in cells treated 
with wortmannin (87.59 ± 7.01% vs. 43.06 ± 9.08%; Fig. 6 D) or 
LY294002 (not depicted) and at least threefold lower (87.59 ± 
7.01% vs. 29.50 ± 6.30%) in cells treated with IC87114 (Fig. 6 D) 
compared with controls. Thus, in live macrophages, inactivation   
of p110 results in newly synthesized TNF that is still correctly 
loaded into p230 tubular carriers but cannot exit the TGN because 
of an apparent block in tubule fission.
The kinase activity of p110 on Golgi membranes would 
produce its product PtdIns(3,4,5)P3 at the same site. Accord-
ingly, using a PtdIns(3,4,5)P3-specific antibody, we were able to 
detect some PtdIns(3,4,5)P3 upon LPS activation that colocal-
ized with newly synthesized TNF at the Golgi (Fig. 7 A), and 
moreover, this staining disappeared from the membranes and 
from attached tubules containing TNF (Fig. 7 B, arrow) after 
treatment with IC87114. Thus, these data point to a pool of 
Figure 6.  p110 regulates fission of TGN-derived, TNF-containing tubular carriers. (A–C) RAW264.7 macrophages coexpressing YFP-p230GRIP (green) 
and TNF-mCherry (red) were treated with LPS only (A; control), LPS and 15 nM wortmannin (B), or LPS and 5 µM IC87114 (C) for at least 30 min before live 
cell imaging. (A) Selected stills from Video 2 depict tubular carriers labeled for YFP-p230GRIP emerging from the TGN and rapidly undergoing fission (white 
and green arrows) to release boluses of TNF-mCherry as cargo (dotted circles in grayscale insets). (B and C) Stills from Videos 3 and 4, respectively, also 
show YFP-p230GRIP tubules loaded with TNF-mCherry that were formed but cannot undergo fission. (D) Counting of fission events in TNF-mCherry–loaded 
YFP-p230GRIP tubules in live cells treated with LPS only (control), LPS and wortmannin (wortm), or LPS and IC87114 (IC87114). 30–40 cells were analyzed 
over eight transfections for each treatment. Error bars indicate mean ± SEM. **, P = 0.0022; ***, P < 0.0001. Regions of colocalization or interest are 
indicated by boxes and are magnified in insets. Bars, 20 µm.1061 PI3K regulates Golgi carrier fission for secretion • Low et al.
and specific phospholipases (Chen et al., 1997; de Figueiredo 
et al., 1999; De Matteis and Luini, 2008; Yang et al., 2008).   
We now show in macrophages that an additional signaling pro-
tein from the PI3K family, PI3K, is also part of this machinery. 
Our findings emerge from multiple approaches, including the use 
of pan-PI3K and isoform-specific pharmacologic inhibitors, as 
well as siRNA-mediated knockdown of the p110 subunit in a 
macrophage cell line. These experiments consistently showed a 
marked, albeit incomplete, block in TNF secretion through selec-
tive retention of the cytokine within cells at the level of the Golgi 
complex. Genetic inactivation of p110 in kinase-inactive mutant 
mice elaborated an even more profound block in the secretion of 
TNF from their BMMs. Our findings further demonstrate a novel 
location of kinase-active p110 on Golgi membranes in activated 
macrophages. Live cell imaging provided the final mechanistic 
insights into the role of p110 on these membranes in facilitat-
ing fission of TGN tubules carrying TNF. Collectively, these 
producing only a small additive effect when used on these cells 
(Fig. S5 A). When dynasore was added to live RAW264.7 macro-
phages coexpressing YFP-p230GRIP and TNF-mCherry, dually 
labeled tubules were formed at the TGN but could not undergo 
fission (Fig. S5, B and C; and Video 5). Inhibition of Dyn2 thus 
appears to mimic the effect of inhibiting p110 on p230/TNF tu-
bule fission. These results now implicate Dyn2 as a necessary fis-
sion component for TNF trafficking in macrophages and a likely 
downstream effector of PI3K.
Discussion
The  formation  and  fission  of  membrane  tubules  arising  from 
the TGN as cargo carriers involves a complex array of proteins, 
many of them signaling proteins, such as the G and  subunits 
(Stow and Heimann, 1998; Jamora et al., 1999), PKD (Liljedahl 
et al., 2001; Hausser et al., 2005; Bard and Malhotra, 2006), 
Figure 7.  Kinase activity of p110 is required for 
TGN  recruitment  of  Dyn2.  (A  and  B)  Unstimulated 
RAW264.7 macrophages (unstim) and macrophages 
activated by LPS for 2 h in the absence or presence 
of 5 µM IC87114 were fixed for immunostaining for 
PtdIns(3,4,5)P3 (red) and TNF (green). DAPI (blue) la-
beling depicts nuclei. Appearance of PtdIns(3,4,5)P3 
upon  activation  at  perinuclear  Golgi  membranes 
colocalizing  with  TNF.  This  PtdIns(3,4,5)P3  detec-
tion was selectively lost in the presence of IC87114.   
(C) RAW264.7 cells transiently transfected with YFP-
p230GRIP  (green)  and  untagged  WT  Dyn2  before 
activation by LPS for 2 h in the presence of DMSO 
(control)  or  5  µM  IC87114  were  fixed  for  Dyn2 
immunostaining (red). (B and C) Arrows indicate ex-
amples of colocalization of Dyn2 with p230 on TGN 
membranes  that  disappeared  upon  IC87114  treat-
ment. (D) Activated cells coexpressing YFP-p230GRIP 
and Dyn2 treated with DMSO (control) or IC87114 
as described in C were analyzed by image analy-
sis to quantify relative distribution intensities of Dyn2 
(TGN vs. cytoplasm). Data are represented as mean 
ratio ± SEM from 30 cells over three transfections. 
***, P < 0.0001. Insets show magnified views of 
boxed regions. Bars, 10 µm.JCB • VOLUME 190 • NUMBER 6 • 2010   1062
et al., 2005, 2008). Along these lines, p110 could act as an   
upstream regulator of Dyn2 either in its recruitment and/or acti-
vation via an LPS-dependent pool of PtdIns(3,4,5)P3. Our local-
ization data (Fig. 7 C) suggest that p110 kinase activity is 
required for the TGN recruitment of Dyn2. Future extensive stud-
ies are now warranted to fully characterize this step in assembling 
this membrane fission machinery.
In macrophages, p110 functions as a key part of an LPS-
induced machinery that simultaneously up-regulates the specific 
carriers and molecules needed to transport the wave of newly syn-
thesized cytokines destined for secretion. It has recently emerged 
that specific steps in constitutive trafficking pathways can be   
modulated by signaling to accommodate cargo volume changes   
(Pulvirenti et al., 2008). We now show that the involvement of 
p110, which also signals downstream of TLRs (Okkenhaug and 
Vanhaesebroeck, 2003), serves to directly link LPS cell activation 
with membrane trafficking capacity. Indeed, fine tuning of traffick-
ing at the level of the TGN carriers and at the subsequent recycling 
endosome and cell surface help to ensure that macrophages elicit 
the temporally controlled sequence of pro- and antiinflammatory 
cytokines so critical for orchestrating an inflammatory response.
p110 is mainly expressed in leukocytes, as demon-
strated by the varying effects of p110 inactivation on B lympho-
cytes, T lymphocytes, natural killer cells, and mast cells in the 
p110
D910A/D910A mice. Anomalies in cytokine release have been 
documented in several of these cell types. Mast cells derived from 
p110
D910A/D910A mice have reduced degranulation and secretion 
of TNF and IL-6, protecting them from anaphylactic allergic re-
actions (Ali et al., 2004). B lymphocytes from these mice have re-
duced TLR-mediated IL-6 and IL-10 secretion (Dil and Marshall, 
2009). Most of these experiments concluded that p110 inactiva-
tion and loss of signaling disrupts cytokine synthesis. Not so in 
natural killer cells from p110 knockout mice (Kim et al., 2007), 
where it was noted that intracellular levels of cytokines were 
sustained even though there was reduced secretion. Our findings 
now show squarely that TLR signaling successfully initiates the 
synthesis of TNF and IL-6 in p110
D910A/D910A BMMs. The defect 
as pinpointed in RAW cells, in BMMs, and by live imaging is at 
the level of trafficking and TGN exit. In showing that p110 func-
tions selectively in the fission of some TGN tubular carriers, we   
can now explain why the secretion of only some cytokines is   
abrogated in different immune cell types from p110
D910A/D910A 
and p110 knockout mice. It will now be important to catalog 
which cytokines are transported by different TGN tubules in vari-
ous cell types. Our findings highlight the potential of p110 in-
hibition as a means for selective abrogation of cytokine secretion   
in the treatment of chronic inflammatory diseases.
Materials and methods
Antibodies, plasmids, and inhibitors
Rabbit polyclonal (Merck) and rat monoclonal (Auspep) antibodies recogniz-
ing mouse TNF (Murray et al., 2005a) and monoclonal antibodies specific 
for GM130 (BD), Dyn2 (BD), and TfnR (Invitrogen) were used. A rabbit poly-
clonal antibody raised against a 20–amino acid C-terminal peptide of p110 
was sourced from Abcam (Vanhaesebroeck et al., 1997). Rabbit antibodies 
against the other p110 isoforms (p110, p110, and p110) were obtained 
from Cell Signaling Technology. A mouse monoclonal antibody specific   
for PtdIns(3,4,5)P3 was obtained from Echelon (Papakonstanti et al., 2007). 
experiments reveal a new site of action and function for PI3K as 
a component of membrane fission machinery at the TGN.
Although the activities of PI3Ks are conventionally con-
fined  to  signal  transduction  at  the  plasma  membrane  or  in   
endocytic processes, prior studies have anticipated some PI3K 
involvement in exocytic carrier functions. Early biochemical   
in vitro studies using isolated Golgi membranes reported a Vps34-
like PI3K activity associated with constitutive carrier budding on 
the TGN (Jones et al., 1993; Jones and Howell, 1997). Another study 
has also proposed a PI3K association with a human TGN protein, 
TGN46 (Hickinson et al., 1997). More recently, a wortmannin- 
insensitive class II PI3K, PI3KC2, has been localized to   
TGN-derived clathrin-coated vesicles (Domin et al., 2000;   
Gaidarov et al., 2001) in addition to its known association with 
neurosecretory granules (Meunier et al., 2005). Interference with 
this kinase was shown to inhibit both clathrin-mediated endo-
cytosis and TGN to lysosomal transport (Gaidarov et al., 2001).   
In this study, PI3KC2 could not rescue the TNF secretory defect 
induced upon knockdown of PI3K (Fig. S3 C). So, it is plau-
sible that different PI3K enzymes may in fact locate to the TGN, 
possibly to distinct subdomains, to selectively regulate transport 
out of the TGN. In this study, the identification of p110 in reg-
ulating TGN export of TNF selectively in p230 tubules (Lock   
et al., 2005; Lieu et al., 2008) further suggests this level of TGN 
suborganization. Whether p110 has an exclusive influence on 
p230 tubules remains to be determined. The soluble cytokine 
cargo IL-6, which can be loaded into multiple types of tubules 
to exit the TGN (Manderson et al., 2007), is only minimally   
affected in its secretion from p110-inactivated macrophages,   
yet its secretion is considerably down-regulated by pan-PI3K   
inhibitors (Fig. S1). Thus, p110 is likely to have selective control 
over p230-mediated TGN export, whereas other PI3K isoforms 
may regulate the carriers for trafficking of other cytokines.
When p110 is inactivated by pan and specific inhibitors 
and in fixed or live cells (Figs. 5 and 6), p230 tubules extend from 
the TGN preloaded with TNF as cargo, but they do not detach. 
This effectively traps TNF in tethered carriers and ultimately 
blocks secretion of this cytokine. All aspects of this trafficking 
phenotype are closely mimicked in our experiments by inhibiting 
the membrane fission GTPase Dyn2. These results first support 
the conclusion that p110 functions at the level of tubular fission, 
and second, they newly implicate Dyn2 itself as part of the spe-
cific fission machinery for TNF/p230 tubules. Similar extension 
of cargo-loaded tubules that cannot detach result from mutation, 
inhibition, and/or knockdown of Dyn2 (Cao et al., 2000; Kreitzer 
et al., 2000; Jaiswal et al., 2009), PKD1-3, and G proteins 
(Liljedahl et al., 2001; Bard and Malhotra, 2006), and these defi-
cits in tubule detachment have been reported as prima facie   
evidence to identify these molecules and others as part of the 
membrane fission machinery. Different TGN tubules appear to 
have disparate fission-inducing pathways in which distinct sig-
naling proteins are positioned as upstream regulators or direct   
effectors of fission. PKD, for example, is a known regulator of 
PI4KIII  (Hausser  et  al.,  2005)  and  thus  of  PtdIns(4)P-  and 
PtdIns(4,5)P2-mediated recruitment of fission factors (Godi et al., 
1999, 2004); however, phospholipase D appears to play a more 
direct role in membrane fission of BARS-induced tubules (Yang 1063 PI3K regulates Golgi carrier fission for secretion • Low et al.
Fixed cells were sequentially incubated with appropriate primary and sec-
ondary antibodies and, in some cases, with Alexa Fluor 633 phalloidin 
(Invitrogen) and DAPI (Invitrogen). Coverslips were mounted in 50% glyc-
erol containing DABCO (1,4-dazabiccyclo-2,2,2-octaine; Sigma-Aldrich) 
or  ProLong  gold  reagent  (Invitrogen).  Epifluorescence  still  images  were 
taken with a 12-Mp differential contrast camera (DP71; Olympus) on an 
upright microscope (BX-51; Olympus) fitted for a 60× NA 1.35 or 100× 
NA 1.4 oil objective using the associated DPController software (version 
2.1; Olympus). Confocal images were acquired on an inverted microscope 
(LSM510 META; Carl Zeiss, Inc.) with a 63× or 100× NA 1.4 oil objective 
and an inverted microscope (LSM710; Carl Zeiss, Inc.) with a 63× NA 
1.4 or 100× NA 1.46 oil objective using the associated META (LSM510) 
or ZEN (LSM510/710) software. For z series, images were sequentially 
captured with 0.4–0.7-µm step intervals, analyzed, and reconstructed in 
3D using LSM, ZEN, and Volocity software (version 3.7; PerkinElmer). All 
images saved or exported in TIFF files after acquisition were analyzed 
using ImageJ (version 1.41; National Institutes of Health) and Photoshop 
(version 9–12; Adobe).
For live cell experiments, RAW macrophages were cultured on glass-
bottom  35-mm  dishes  (MatTek).  Real-time  epifluorescence  imaging  was   
performed on a 100× NA 1.4 microscope (IX81; Olympus) with a 12-bit 
1,376 × 1,032–pixel high resolution camera with cells bathed in CO2-
independent medium (Invitrogen; Lock et al., 2005; Murray et al., 2005a; 
Manderson et al., 2007) containing LPS and a PI3K inhibitor or dynasore 
and kept at 37°C inside the microscope incubator. Time-resolved image 
acquisition was controlled using the associated CelR software (version 2.5; 
Olympus). Frame capture rates were 0.5 s–0.1 min, with total acquisition 
periods of 15 s–40 min. Individual channels were captured sequentially, 
with typical capture rates of 0.1–1 s for YFP and 0.08–0.4 s for mCherry. 
Videos 1–5 were analyzed, cropped (if required), constructed using CelR, 
ImageJ, and Volocity, and exported as QuickTime videos (Apple) with play-
back speeds of 3 frames/s.
For  flow  cytometry,  cultured  cells  were  harvested,  pelleted,  and 
resuspended sequentially in PBS, 2% paraformaldehyde (30 min), BSA 
buffers, and PE-conjugated rabbit anti-TNF antibody (1 h) to detect cell 
surface TNF. To subsequently detect intracellular TNF, cells were pelleted 
and resuspended in 0.1% Triton X-100 (5 min) followed by rat anti-TNF 
antibody (1 h) and Alexa Fluor 488 goat anti–rat IgG (30 min) with in-
between blocking washes. All steps were performed at 4°C. Cells were 
finally subjected to flow cytometric analysis on an LSR II (BD) using the as-
sociated acquisition software (FACSDiva; BD). Data were analyzed using 
WinMDI software (version 2.8; J. Trotter, The Scripps Research Institute,   
La Jolla, CA). Cells were gated on forward scatter/side scatter characteris-
tics and on unstained and nonspecific isotype antibody controls. Levels of 
TNF fluorescence in each channel were assessed on the basis of mean fluores-
cence intensity in arbitrary units. All isotype-matched antibodies were pur-
chased from BD.
Preparation of cell lysates, SDS-PAGE separation, and Western blotting
Cells  were  washed  with  PBS,  harvested,  and  lysed  in  10  mM  Tris,   
pH 7.4, containing 1 mM EDTA, 0.5% Triton X-100, and Complete protease 
inhibitors (Roche) by passaging through a series of successively smaller 
needles. Lysates were centrifuged for 10 min at 17,000 g, and super-
natants were assayed for protein content (Bradford assay; Bio-Rad Labora-
tories)  before  SDS-PAGE  protein  separation  and  analysis  by  Western 
blotting as described previously (Shurety et al., 2000). A stacked Golgi 
membrane fraction and subsequent Golgi-derived budded carriers were 
prepared from RAW264.7 macrophages stimulated with LPS for 2 h by 
a previously described method (Heimann et al., 1999; Wylie et al., 
2003). In brief, postnuclear supernatants of homogenized macrophages 
were separated by ultracentrifugation on a discontinuous sucrose gradi-
ent to produce a stacked Golgi fraction. Both cytosol and Golgi stacks 
were sampled for Western blotting. The Golgi membranes were incu-
bated in HKM buffer (20 mM KCl, 2.5 mM Mg acetate, and 25 mM 
Hepes-KOH, pH 7.4) in the presence of 0.1 mM GTP-S and cytosol for 
30 min at 37°C to allow budding of carriers. Golgi membranes were   
recovered by centrifugation at 17,500 g for 10 min at 4°C. Budded car-
riers  were  recovered  from  the  supernatant  by  discontinuous  sucrose   
gradient centrifugation as described previously (Heimann et al., 1999). 
Samples of cytosol, budded carriers, and remnant Golgi were analyzed 
by Western blotting.
Statistical analysis and significance
Statistical  analysis  was  performed  by  two-tailed  Student’s  t  test  using 
Prism software (version 5; GraphPad Software, Inc.). P < 0.05 was con-
sidered significant.
Secondary antibodies used were R-phycoerythrin (PE)-conjugated monoclonal 
antibody to mouse TNF (BD; Murray et al., 2005a) and Cy3- or Alexa Fluor 
488–conjugated anti–mouse, –rabbit, or –rat IgGs (all obtained from Jackson 
ImmunoResearch Laboratories, Inc.). cDNA plasmids used for live cell imag-
ing encoding full-length TNF N-terminally tagged with mCherry (TNF-mCherry) 
or the GRIP domain of p230 C-terminally tagged with YFP (YFP-p230GRIP) 
have all been previously described (Lock et al., 2005; Manderson et al.,   
2007; Lieu et al., 2008). Plasmids encoding untagged, full-length human 
WT p110 or kinase-dead p110 (R894P) have been described previously   
(Vanhaesebroeck et al., 1997). PI3KC2-GFP was provided by J. Domin (Impe-
rial College, London, England, UK). A plasmid encoding untagged, full-length 
WT Dyn2 was provided by M.A. McNiven (Mayo Clinic, Rochester, MN).
TAPI was purchased from EMD. Wortmannin and LY294002 were 
obtained from Sigma-Aldrich and Cell Signaling Technology, respectively. 
Small  molecule  p110-selective  inhibitors  YM024  (p110),  TGX-221 
(p110), and AS252424 (p110) were provided by S. Jackson (Austra-
lian Centre for Blood Diseases, Monash University, Melbourne, Victoria, 
Australia), and IC87114 (p110) was supplied by Symansis. Dynasore 
was  obtained  from  Sigma-Aldrich.  All  inhibitors  were  reconstituted  in 
DMSO  (Sigma-Aldrich)  with  final  concentration  of  DMSO  in  assays  at 
0.1% maximum.
Cell culture, activation, and transfection
The mouse RAW264.7 macrophage cell line was cultured in RPMI1640 
(BioWhittaker;  supplemented  with  10%  heat-inactivated  Serum  Supreme 
[Cambrex] and 1%  l-glutamine [Invitrogen]) in humidified 5% CO2/95% 
air atmosphere at 37°C as previously described (Shurety et al., 2000). 
For experiments, cells were activated by addition of 100 ng/ml LPS (from 
Salmonella minnesota Re595; Sigma-Aldrich), and in some experiments, 
TNF cleavage was blocked with 10 µM TAPI. For transient expression of 
cDNAs or siRNAs, cells at 30–50% confluence were transfected using   
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions 
and as previously described (Manderson et al., 2007). Cells were typically 
used for experiments 2–6 h after transfection of cDNAs.
To silence mouse p110, cells were transfected with three different 
specific siRNAs (Pik3cd Stealth; numbered 1–3; Invitrogen), cultured for 
24 h, retransfected under the same conditions, and cultured for another   
24 h before LPS activation (2 h) in the absence or presence of TAPI.   
Because siRNA3 reproducibly gave the strongest knockdown (Fig. 2), it 
was used in all subsequent si/rescue experiments. Human p110 (WT or 
kinase dead) plasmids are siRNA3 resistant based on a different targeted 
sequence, and these were separately transfected into p110-si–depleted 
cultures for 6 h.
Preparation of mouse BMMs
BMMs were derived by ex vivo differentiation of bone marrow progenitors 
extracted from femurs of at least 6- to 8-wk-old mice in accordance with 
the Australian animal ethics guidelines. BMMs were prepared from both 
p110
D910A/D910A kinase-dead mutant mice (Okkenhaug et al., 2002), and 
WT littermates inbred on the C57BL/6 genetic background were kept under 
pathogen-free conditions. Bone marrow cells were pooled from equal num-
bers of age-matched mice in each experiment and cultured for 7 d in growth 
medium supplemented with CSF-1 (10,000 U/ml; provided by Novartis) 
before use, as previously described (Hume and Gordon, 1983).
Assaying cytokine secretion
To determine the levels of secreted TNF or IL-6, macrophages (RAW, 2 × 
10
5/ml; BMM, 5 × 10
5/ml) were stimulated with LPS, and commercial 
ELISA kits (BD OptEIA; BD) or the Cytometric Bead Array system (BD) was 
used to quantify cytokine concentrations in samples according to the manu-
facturer’s instructions. For assaying TNF secretion in the presence of wort-
mannin, LY294002, p110-selective inhibitors, or dynasore (each drug at 
the concentrations indicated in Figs. 1–7), DMSO (0.1% final) was added 
with LPS into the supernatant.
Fluorescence microscopy, live cell imaging, and flow cytometry
Immunofluorescence  staining  was  performed  as  previously  described   
(Pagan et al., 2003) on coverslip-adherent macrophages fixed for 1 h at 
room temperature in 4% paraformaldehyde. For some experiments (Fig. 4 C   
and Fig. S4), adherent macrophages were briefly air dried, and their ex-
posed membranes ripped off by gentle application (30 s) and removal of 
partially damp filter paper (Millipore; Wylie et al., 1999). Remnant cyto-
skeletons, basal membranes, and organelles left adhering to the coverslip 
were used for immunostaining. Washes were performed in PBS with or 
without BSA for blocking. Where required, cells were permeabilized in 
0.1% Triton X-100 for 5 min (or 0.5% saponin for 10 min; Fig. 7, A and B).   JCB • VOLUME 190 • NUMBER 6 • 2010   1064
the trans-Golgi network and present in clathrin-coated vesicles. J. Biol. 
Chem. 275:11943–11950. doi:10.1074/jbc.275.16.11943
Fruman, D.A., R.E. Meyers, and L.C. Cantley. 1998. Phosphoinositide kinases. 
Annu. Rev. Biochem. 67:481–507. doi:10.1146/annurev.biochem.67.1.481
Gaidarov,  I.,  M.E.  Smith,  J.  Domin,  and  J.H.  Keen.  2001.  The  class  II   
phosphoinositide 3-kinase C2alpha is activated by clathrin and regulates 
clathrin-mediated membrane trafficking. Mol. Cell. 7:443–449. doi:10.1016/ 
S1097-2765(01)00191-5
Gleeson, P.A., J.G. Lock, M.R. Luke, and J.L. Stow. 2004. Domains of the TGN: 
coats,  tethers  and  G  proteins.  Traffic.  5:315–326.  doi:10.1111/j.1398-
9219.2004.00182.x
Godi, A., P. Pertile, R. Meyers, P. Marra, G. Di Tullio, C. Iurisci, A. Luini, 
D. Corda, and M.A. De Matteis. 1999. ARF mediates recruitment of   
PtdIns-4-OH  kinase-beta  and  stimulates  synthesis  of  PtdIns(4,5)P2   
on the Golgi complex. Nat. Cell Biol. 1:280–287. doi:10.1038/12993
Godi, A., A. Di Campli, A. Konstantakopoulos, G. Di Tullio, D.R. Alessi, G.S. 
Kular, T. Daniele, P. Marra, J.M. Lucocq, and M.A. De Matteis. 2004. 
FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF 
and PtdIns(4)P. Nat. Cell Biol. 6:393–404. doi:10.1038/ncb1119
Gordon, S. 2007. The macrophage: past, present and future. Eur. J. Immunol. 
37(Suppl 1):S9–S17. doi:10.1002/eji.200737638
Hausser, A., P. Storz, S. Märtens, G. Link, A. Toker, and K. Pfizenmaier. 2005. 
Protein kinase D regulates vesicular transport by phosphorylating and   
activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex. 
Nat. Cell Biol. 7:880–886. doi:10.1038/ncb1289
Heimann, K., J.M. Percival, R. Weinberger, P. Gunning, and J.L. Stow. 1999. 
Specific isoforms of actin-binding proteins on distinct populations of 
Golgi-derived vesicles. J. Biol. Chem. 274:10743–10750. doi:10.1074/ 
jbc.274.16.10743
Hickinson, D.M., J.M. Lucocq, M.C. Towler, S. Clough, J. James, S.R. James, C.P.  
Downes, and S. Ponnambalam. 1997. Association of a phosphatidylinositol- 
specific  3-kinase  with  a  human  trans-Golgi  network  resident  protein. 
Curr. Biol. 7:987–990. doi:10.1016/S0960-9822(06)00418-0
Hirschberg, K., C.M. Miller, J. Ellenberg, J.F. Presley, E.D. Siggia, R.D. Phair, and 
J. Lippincott-Schwartz. 1998. Kinetic analysis of secretory protein traffic 
and characterization of golgi to plasma membrane transport intermediates 
in living cells. J. Cell Biol. 143:1485–1503. doi:10.1083/jcb.143.6.1485
Hume, D.A., and S. Gordon. 1983. Optimal conditions for proliferation of bone 
marrow-derived mouse macrophages in culture: the roles of CSF-1, serum,   
Ca2+,  and  adherence.  J.  Cell.  Physiol.  117:189–194.  doi:10.1002/ 
jcp.1041170209
Jackson, S.P., S.M. Schoenwaelder, I. Goncalves, W.S. Nesbitt, C.L. Yap, C.E. 
Wright, V. Kenche, K.E. Anderson, S.M. Dopheide, Y. Yuan, et al. 2005. 
PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat. Med. 
11:507–514. doi:10.1038/nm1232
Jaiswal, J.K., V.M. Rivera, and S.M. Simon. 2009. Exocytosis of post-Golgi 
vesicles is regulated by components of the endocytic machinery. Cell. 
137:1308–1319. doi:10.1016/j.cell.2009.04.064
Jamora, C., N. Yamanouye, J. Van Lint, J. Laudenslager, J.R. Vandenheede, D.J. 
Faulkner, and V. Malhotra. 1999. Gbetagamma-mediated regulation of 
Golgi organization is through the direct activation of protein kinase D. 
Cell. 98:59–68. doi:10.1016/S0092-8674(00)80606-6
Jones, S.M., and K.E. Howell. 1997. Phosphatidylinositol 3-kinase is required 
for the formation of constitutive transport vesicles from the TGN. J. Cell 
Biol. 139:339–349. doi:10.1083/jcb.139.2.339
Jones,  S.M.,  J.R.  Crosby,  J.  Salamero,  and  K.E.  Howell.  1993. A  cytosolic 
complex of p62 and rab6 associates with TGN38/41 and is involved in 
budding of exocytic vesicles from the trans-Golgi network. J. Cell Biol. 
122:775–788. doi:10.1083/jcb.122.4.775
Jones, S.M., K.E. Howell, J.R. Henley, H. Cao, and M.A. McNiven. 1998. Role 
of dynamin in the formation of transport vesicles from the trans-Golgi 
network. Science. 279:573–577. doi:10.1126/science.279.5350.573
Jou, S.T., N. Carpino, Y. Takahashi, R. Piekorz, J.R. Chao, N. Carpino, D. Wang, 
and J.N. Ihle. 2002. Essential, nonredundant role for the phosphoinositide   
3-kinase p110delta in signaling by the B-cell receptor complex. Mol. 
Cell. Biol. 22:8580–8591. doi:10.1128/MCB.22.24.8580-8591.2002
Keller, P., D. Toomre, E. Díaz, J. White, and K. Simons. 2001. Multicolour im-
aging of post-Golgi sorting and trafficking in live cells. Nat. Cell Biol. 
3:140–149. doi:10.1038/35055042
Kim, N., A. Saudemont, L. Webb, M. Camps, T. Ruckle, E. Hirsch, M. Turner, 
and F. Colucci. 2007. The p110delta catalytic isoform of PI3K is a key 
player in NK-cell development and cytokine secretion. Blood. 110:3202–
3208. doi:10.1182/blood-2007-02-075366
Kreitzer, G., A. Marmorstein, P. Okamoto, R. Vallee, and E. Rodriguez-Boulan. 
2000. Kinesin and dynamin are required for post-Golgi transport of a 
plasma-membrane  protein.  Nat.  Cell  Biol.  2:125–127.  doi:10.1038/ 
35000081
Online supplemental material
Fig. S1 shows the effects of pan-PI3K inhibitors on LPS-stimulated cytokine 
secretion  from  RAW264.7  macrophages.  Fig.  S2  shows  representative 
density plots from flow cytometric analysis of surface and intracellular TNF 
levels in RAW264.7 and BMMs. Fig. S3 shows rescue of p110 expression 
and TNF trafficking in siRNA–knocked down RAW264.7 macrophages. 
Fig. S4 shows 3D profiles of p110 localization at the Golgi membranes. 
Fig. S5 shows the effects of inhibiting GTPase Dyn2 on TNF secretion and 
tubular fission. Video 1 shows a 3D reconstruction demonstrating in situ 
association of p110 with Golgi membranes. Video 2 shows a typically dy-
namic p230/TNF tubule undergoing fission at the TGN in a representative 
activated macrophage. Video 3 shows a p230/TNF tubule that has formed 
at the TGN but cannot undergo fission in representative activated macro-
phages treated with wortmannin. Video 4 shows a p230/TNF tubule that has 
formed at the TGN but cannot undergo fission in a representative activated 
macrophage treated with IC87114. Video 5 shows p230/TNF tubules that 
formed at the TGN but cannot undergo fission in a representative activated 
macrophage treated with dynasore. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201001028/DC1.
We thank Tatiana Khromykh, Juliana Venturato, and Darren Brown for techni-
cal assistance and colleagues whom we have acknowledged for kindly pro-
viding reagents.
The work was funded by grants and fellowships (to J.L. Stow, F.A. Meunier, 
and  R.D.  Teasdale)  from  the  National  Health  and  Medical  Research   
Council of Australia. Confocal microscopy was performed at the Australian 
Cancer  Research  Foundation  (ACRF)/Institute  for  Molecular  Bioscience   
Dynamic Imaging Facility, which was established with the support of the ACRF.   
B. Vanhaesebroeck is an advisor to Intellikine (San Diego, CA).
Submitted: 7 January 2010
Accepted: 20 August 2010
References
Ali, K., A. Bilancio, M. Thomas, W. Pearce, A.M. Gilfillan, C. Tkaczyk, N. 
Kuehn, A. Gray, J. Giddings, E. Peskett, et al. 2004. Essential role for 
the p110delta phosphoinositide 3-kinase in the allergic response. Nature. 
431:1007–1011. doi:10.1038/nature02991
Bard, F., and V. Malhotra. 2006. The formation of TGN-to-plasma-membrane 
transport carriers. Annu. Rev. Cell Dev. Biol. 22:439–455. doi:10.1146/
annurev.cellbio.21.012704.133126
Beutler, B.A. 1999. The role of tumor necrosis factor in health and disease.  
J. Rheumatol. Suppl. 57:16–21.
Braun, V., C. Deschamps, G. Raposo, P. Benaroch, A. Benmerah, P. Chavrier, 
and F. Niedergang. 2007. AP-1 and ARF1 control endosomal dynamics 
at sites of FcR mediated phagocytosis. Mol. Biol. Cell. 18:4921–4931. 
doi:10.1091/mbc.E07-04-0392
Cao, H., H.M. Thompson, E.W. Krueger, and M.A. McNiven. 2000. Disruption 
of Golgi structure and function in mammalian cells expressing a mutant 
dynamin. J. Cell Sci. 113:1993–2002.
Chen, Y.G.,  A.  Siddhanta,  C.D.  Austin,  S.M.  Hammond,  T.C.  Sung,  M.A. 
Frohman, A.J. Morris, and D. Shields. 1997. Phospholipase D stimulates 
release of nascent secretory vesicles from the trans-Golgi network. J. Cell 
Biol. 138:495–504. doi:10.1083/jcb.138.3.495
Clayton,  E.,  G.  Bardi,  S.E.  Bell,  D.  Chantry,  C.P.  Downes, A.  Gray,  L.A. 
Humphries, D. Rawlings, H. Reynolds, E. Vigorito, and M. Turner. 2002. 
A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase 
in B cell development and activation. J. Exp. Med. 196:753–763. doi:10 
.1084/jem.20020805
de Figueiredo, P., R.S. Polizotto, D. Drecktrah, and W.J. Brown. 1999. Membrane 
tubule-mediated reassembly and maintenance of the Golgi complex is dis-
rupted by phospholipase A2 antagonists. Mol. Biol. Cell. 10:1763–1782.
De Matteis, M.A., and A. Luini. 2008. Exiting the Golgi complex. Nat. Rev. Mol. 
Cell Biol. 9:273–284. doi:10.1038/nrm2378
Deane, J.A., and D.A. Fruman. 2004. Phosphoinositide 3-kinase: diverse roles in 
immune cell activation. Annu. Rev. Immunol. 22:563–598. doi:10.1146/
annurev.immunol.22.012703.104721
Di Paolo, G., and P. De Camilli. 2006. Phosphoinositides in cell regulation and 
membrane dynamics. Nature. 443:651–657. doi:10.1038/nature05185
Dil, N., and A.J. Marshall. 2009. Role of phosphoinositide 3-kinase p110 delta 
in TLR4- and TLR9-mediated B cell cytokine production and differentia-
tion. Mol. Immunol. 46:1970–1978. doi:10.1016/j.molimm.2009.03.010
Domin, J., I. Gaidarov, M.E. Smith, J.H. Keen, and M.D. Waterfield. 2000. 
The class II phosphoinositide 3-kinase PI3K-C2alpha is concentrated in 1065 PI3K regulates Golgi carrier fission for secretion • Low et al.
Stow,  J.L.,  and  K.  Heimann.  1998.  Vesicle  budding  on  Golgi  membranes: 
regulation by G proteins and myosin motors. Biochim. Biophys. Acta. 
1404:161–171. doi:10.1016/S0167-4889(98)00055-X
Stow, J.L., A.P. Manderson, and R.Z. Murray. 2006. SNAREing immunity: the 
role of SNAREs in the immune system. Nat. Rev. Immunol. 6:919–929. 
doi:10.1038/nri1980
Stow,  J.L.,  P.C.  Low,  C.  Offenhäuser,  and  D.  Sangermani.  2009.  Cytokine 
secretion  in  macrophages  and  other  cells:  pathways  and  mediators. 
Immunobiology. 214:601–612. doi:10.1016/j.imbio.2008.11.005
Vanhaesebroeck, B., and M.D. Waterfield. 1999. Signaling by distinct classes 
of phosphoinositide 3-kinases. Exp. Cell Res. 253:239–254. doi:10.1006/ 
excr.1999.4701
Vanhaesebroeck,  B.,  M.J.  Welham,  K.  Kotani,  R.  Stein,  P.H.  Warne,  M.J. 
Zvelebil,  K.  Higashi,  S. Volinia,  J.  Downward,  and  M.D. Waterfield. 
1997. P110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc. 
Natl. Acad. Sci. USA. 94:4330–4335. doi:10.1073/pnas.94.9.4330
Vanhaesebroeck, B., S.J. Leevers, K. Ahmadi, J. Timms, R. Katso, P.C. Driscoll, 
R. Woscholski, P.J. Parker, and M.D. Waterfield. 2001. Synthesis and 
function  of  3-phosphorylated  inositol  lipids.  Annu.  Rev.  Biochem. 
70:535–602. doi:10.1146/annurev.biochem.70.1.535
Vanhaesebroeck, B., K. Ali, A. Bilancio, B. Geering, and L.C. Foukas. 2005. 
Signalling by PI3K isoforms: insights from gene-targeted mice. Trends 
Biochem. Sci. 30:194–204. doi:10.1016/j.tibs.2005.02.008
Wylie, F., K. Heimann, T.L. Le, D. Brown, G. Rabnott, and J.L. Stow. 1999. 
GAIP, a Galphai-3-binding protein, is associated with Golgi-derived ves-
icles and protein trafficking. Am. J. Physiol. 276:C497–C506.
Wylie, F.G., J.G. Lock, L. Jamriska, T. Khromykh, D.L. Brown, and J.L. Stow. 
2003. GAIP participates in budding of membrane carriers at the trans-
Golgi network. Traffic. 4:175–189.
Yang, Z., H. Li, Z. Chai, M.J. Fullerton, Y. Cao, B.H. Toh, J.W. Funder, and J.P. 
Liu. 2001. Dynamin II regulates hormone secretion in neuroendocrine 
cells. J. Biol. Chem. 276:4251–4260. doi:10.1074/jbc.M006371200
Yang, J.S., S.Y. Lee, S. Spanò, H. Gad, L. Zhang, Z. Nie, M. Bonazzi, D. Corda, 
A. Luini, and V.W. Hsu. 2005. A role for BARS at the fission step of 
COPI vesicle formation from Golgi membrane. EMBO J. 24:4133–4143. 
doi:10.1038/sj.emboj.7600873
Yang,  J.S.,  H.  Gad,  S.Y.  Lee,  A.  Mironov,  L.  Zhang,  G.V.  Beznoussenko,   
C. Valente, G. Turacchio, A.N. Bonsra, G. Du, et al. 2008. A role for 
phosphatidic acid in COPI vesicle fission yields insights into Golgi   
maintenance. Nat. Cell Biol. 10:1146–1153. doi:10.1038/ncb1774
Lieu,  Z.Z.,  J.G.  Lock,  L.A.  Hammond,  N.L.  La  Gruta,  J.L.  Stow,  and  P.A. 
Gleeson. 2008. A trans-Golgi network golgin is required for the regulated 
secretion of TNF in activated macrophages in vivo. Proc. Natl. Acad. Sci. 
USA. 105:3351–3356. doi:10.1073/pnas.0800137105
Liljedahl, M., Y. Maeda, A. Colanzi, I. Ayala, J. Van Lint, and V. Malhotra. 
2001.  Protein  kinase  D  regulates  the  fission  of  cell  surface  destined 
transport  carriers  from  the  trans-Golgi  network.  Cell.  104:409–420. 
doi:10.1016/S0092-8674(01)00228-8
Lindmo,  K.,  and  H.  Stenmark.  2006.  Regulation  of  membrane  traffic  by 
phosphoinositide 3-kinases. J. Cell Sci. 119:605–614. doi:10.1242/ 
jcs.02855
Lock, J.G., L.A. Hammond, F. Houghton, P.A. Gleeson, and J.L. Stow. 2005. 
E-cadherin  transport  from  the  trans-Golgi  network  in  tubulovesicu-
lar carriers is selectively regulated by golgin-97. Traffic. 6:1142–1156. 
doi:10.1111/j.1600-0854.2005.00349.x
Macia, E., M. Ehrlich, R. Massol, E. Boucrot, C. Brunner, and T. Kirchhausen. 
2006.  Dynasore,  a  cell-permeable  inhibitor  of  dynamin.  Dev.  Cell. 
10:839–850. doi:10.1016/j.devcel.2006.04.002
Manderson, A.P., J.G. Kay, L.A. Hammond, D.L. Brown, and J.L. Stow. 2007. 
Subcompartments  of  the  macrophage  recycling  endosome  direct  the 
differential secretion of IL-6 and TNFalpha. J. Cell Biol. 178:57–69. 
doi:10.1083/jcb.200612131
Martin,  T.F.  1998.  Phosphoinositide  lipids  as  signaling  molecules:  common 
themes for signal transduction, cytoskeletal regulation, and membrane 
trafficking. Annu. Rev. Cell Dev. Biol. 14:231–264. doi:10.1146/annurev 
.cellbio.14.1.231
Mellman, I., and G. Warren. 2000. The road taken: past and future foundations 
of  membrane  traffic.  Cell.  100:99–112.  doi:10.1016/S0092-8674(00) 
81687-6
Meunier, F.A., S.L. Osborne, G.R. Hammond, F.T. Cooke, P.J. Parker, J. Domin, 
and G. Schiavo. 2005. Phosphatidylinositol 3-kinase C2alpha is essential 
for ATP-dependent priming of neurosecretory granule exocytosis. Mol. 
Biol. Cell. 16:4841–4851. doi:10.1091/mbc.E05-02-0171
Munro, S., and B.J. Nichols. 1999. The GRIP domain - a novel Golgi-targeting 
domain  found  in  several  coiled-coil  proteins.  Curr.  Biol.  9:377–380. 
doi:10.1016/S0960-9822(99)80166-3
Murray,  R.Z.,  J.G.  Kay,  D.G.  Sangermani,  and  J.L.  Stow.  2005a.  A  role 
for  the  phagosome  in  cytokine  secretion.  Science.  310:1492–1495. 
doi:10.1126/science.1120225
Murray,  R.Z.,  F.G. Wylie,  T.  Khromykh,  D.A.  Hume,  and  J.L.  Stow.  2005b. 
Syntaxin 6 and Vti1b form a novel SNARE complex, which is up-regulated 
in activated macrophages to facilitate exocytosis of tumor necrosis Factor-
alpha. J. Biol. Chem. 280:10478–10483. doi:10.1074/jbc.M414420200
Okkenhaug, K., and B. Vanhaesebroeck. 2003. PI3K in lymphocyte develop-
ment,  differentiation  and  activation.  Nat.  Rev.  Immunol.  3:317–330. 
doi:10.1038/nri1056
Okkenhaug, K., A. Bilancio, G. Farjot, H. Priddle, S. Sancho, E. Peskett, W. 
Pearce, S.E. Meek, A. Salpekar, M.D. Waterfield, et al. 2002. Impaired 
B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant 
mice. Science. 297:1031–1034.
Pagan, J.K., F.G. Wylie, S. Joseph, C. Widberg, N.J. Bryant, D.E. James, and J.L. 
Stow. 2003. The t-SNARE syntaxin 4 is regulated during macrophage 
activation to function in membrane traffic and cytokine secretion. Curr. 
Biol. 13:156–160. doi:10.1016/S0960-9822(03)00006-X
Papakonstanti, E.A., A.J. Ridley, and B. Vanhaesebroeck. 2007. The p110delta 
isoform of PI 3-kinase negatively controls RhoA and PTEN. EMBO J. 
26:3050–3061. doi:10.1038/sj.emboj.7601763
Park, Y.C., C.H. Lee, H.S. Kang, H.T. Chung, and H.D. Kim. 1997. Wortmannin, 
a  specific  inhibitor  of  phosphatidylinositol-3-kinase,  enhances  LPS- 
induced NO production from murine peritoneal macrophages. Biochem. 
Biophys. Res. Commun. 240:692–696. doi:10.1006/bbrc.1997.7722
Polishchuk,  R.S.,  E.V.  Polishchuk,  P.  Marra,  S.  Alberti,  R.  Buccione,  A. 
Luini, and A.A. Mironov. 2000. Correlative light-electron microscopy 
reveals  the  tubular-saccular  ultrastructure  of  carriers  operating  be-
tween Golgi apparatus and plasma membrane. J. Cell Biol. 148:45–58. 
doi:10.1083/jcb.148.1.45
Pulvirenti,  T.,  M.  Giannotta,  M.  Capestrano,  M.  Capitani,  A.  Pisanu,  R.S. 
Polishchuk,  E.  San  Pietro,  G.V.  Beznoussenko,  A.A.  Mironov,  G. 
Turacchio,  et  al.  2008. A  traffic-activated  Golgi-based  signalling  cir-
cuit  coordinates  the  secretory  pathway.  Nat.  Cell  Biol.  10:912–922. 
doi:10.1038/ncb1751
Sadhu, C., B. Masinovsky, K. Dick, C.G. Sowell, and D.E. Staunton. 2003. 
Essential role of phosphoinositide 3-kinase delta in neutrophil directional 
movement. J. Immunol. 170:2647–2654.
Shurety, W., A. Merino-Trigo, D. Brown, D.A. Hume, and J.L. Stow. 2000. 
Localization and post-Golgi trafficking of tumor necrosis factor-alpha 
in macrophages. J. Interferon Cytokine Res. 20:427–438. doi:10.1089/ 
107999000312379